pyrindamycin a has been researched along with Leukemia P388 in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Inouye, S; Ishii, S; Kariya, Y; Kondo, S; Nagasawa, M; Yamamoto, H | 1 |
| Kodama, Y; Kondo, S; Nakazawa, T; Ohba, K; Sasaki, T; Sezaki, M; Shomura, T; Takeuchi, Y; Watabe, H; Yamamoto, H | 1 |
2 other study(ies) available for pyrindamycin a and Leukemia P388
| Article | Year |
|---|---|
Antitumor activity of pyrindamycins A and B.
Topics: Animals; Antibiotics, Antineoplastic; DNA, Neoplasm; Duocarmycins; Humans; Indoles; Leukemia L1210; Leukemia P388; Male; Mice; Molecular Structure; Neoplasm Proteins; Pyrroles; RNA, Neoplasm; Specific Pathogen-Free Organisms; Tumor Cells, Cultured | 1989 |
Pyrindamycins A and B, new antitumor antibiotics.
Topics: Animals; Antibiotics, Antineoplastic; Chemical Phenomena; Chemistry; Duocarmycins; Fermentation; Indoles; Leukemia P388; Magnetic Resonance Spectroscopy; Microbial Sensitivity Tests; Pyrroles; Streptomyces | 1988 |